Skip to main content
. 2020 Feb 14;11:67. doi: 10.3389/fphar.2020.00067

Table 1.

Data set composition for model development.

Data set composition Cholestasis Cirrhosis Hepatitis Steatosis
Positive Negative Positive Negative Positive Negative Positive Negative
Drug Train 47 47 37 42 84 84 48 52
Test 12 58 10 63 56 21 12 53
Ratio (8:2) (4.5:5.5) (8:2) (4:6) (6:4) (8:2) (8:2) (5:5)
Drug metabolite Train 64 69 54 56 101 100 77 81
Test 17 57 14 70 84 26 20 45
Ratio (8:2) (5.5:4.5) (8:2) (4.5:5.5) (5.5:4.5) (8:2) (8:2) (6.5:3.5)